ALS
ALS TDI is seeking a Scientist II to co-lead the management, analysis, and interpretation of complex natural history and multiomics data related to amyotrophic lateral sclerosis (ALS). The role involves developing data management strategies, harmonizing heterogeneous datasets, and applying statistical and machine learning techniques to identify disease biomarkers and therapeutic targets. The position requires strong expertise in data science, bioinformatics, and biomedical research methodologies, with a focus on reproducible, version-controlled analytic work.
Headquarters
Bowen Hills, Queensland, Australia
Company Size
10001+ employees
Founded
1863
ALS Global provides comprehensive environmental testing, laboratory services, and scientific solutions across industries. Explore our cutting-edge services for water, air, soil, and more. Trust ALS for reliable results, expert analysis, and global reach.
ALS: Net earnings soared to $299.4M in 2025, fueled by a major royalty sale and portfolio expansion
1 day ago
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
2 weeks ago
New ALS drug stabilizes decline with improved strength, mobility for some
Dec 22, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ALS.
10 promising biotechs racing toward a cure for ALS
1 month ago